Trial finds benefits of 16-hour fasting are evident for at least 1 year, regardless of eating window timing
Powered by WPeMatico
Powered by WPeMatico
Powered by WPeMatico
Powered by WPeMatico
Powered by WPeMatico
New Delhi: Despite the proposal for a model law to protect healthcare professionals from violence being acknowledged by the National Task Force (NTF), there has been no significant development in this regard.
As per the recent RTI response, the National Task Force, which was constituted by the Supreme Court to ensure the safety of doctors and healthcare workers, had requested the Government to prepare the draft model law for States/Union Territories to protect healthcare professionals. Consequently, the Union Health Ministry on September 5, 2024, constituted a sub-group with DGMS (Navy) as the convener, under the National Task Force, to strengthen the legal framework across all States. However, there is no clarity on any development in this regard, the Ministry of Home Affairs informed in response to the RTI, filed by Dr. KV Babu, a Kerala-based Health activist.
The information comes after the Union Health Minister, Mansukh Mandaviya, clarified in the Parliament earlier this year that the existing laws already have provisions to protect doctors from violence.
Dr. Babu, who has been pursuing the matter, filed RTI applications on 29th December 2024 and 30th March 2025 with the Home Ministry seeking the details of the state law prepared to address incidents of violence against doctors.
Dr. Babu informed Medical Dialogues that even though the Home Ministry acknowledged such a proposal for drafting a state law, both the Home Ministry and MoH are clueless about the development of the legislation.
The Home Ministry, in its reply, informed in February 2025 that “…after the first meeting of the National Task Force (NTF), BPR&D vide aforementioned letter was, inter-alia requested to prepare the draft model law for State/UTs for protection of healthcare professionals.”
“Subsequently, the Ministry of Health and Family Welfare vide its OM dated 05.09.2024 constituted a sub-group with DGMS (Navy) as the convener, under the NTF, for strengthening the legal framework across all states,” the RTI reply stated.
“No further information in this regard is available with the undersigned CPIO. Further, no communication has been issued by this ministry to the state home departments regarding the model state law,” it further mentioned.
The RTI further informed that the relevant information may be available with the Union Health Ministry, which is primarily concerned with the subject, or the convener of the sub-group.
Commenting on the matter, Dr. Babu said, “The proposal to enact a Central Law for protection of HCWs was mooted by the Ministry of Health in 2019. But, the GOI clarified in its RTI reply in 2024 September that it was decided not to enact a separate legislation for prohibiting violence against doctors and other health care professionals.”
“Following the tragic incident in RG Kar medical college ,there was a proposal from the part of the GOI to draft a model state law for the protection of HCWs as acknowledged by the CPIO of Home ministry in their RTI reply. Now,it also seems to be kept in cold storage.This is a very sad state of affairs and hope the Union Home Ministry will pursue the model state law,” he added.
Medical Dialogues had earlier reported that the NTF, constituted by the Supreme Court, had informed last year in November that there was no requirement for a separate central law to protect the doctors.
The apex Court had constituted the National Task Force after taking suo motu cognisance of the rape and murder case of a postgraduate trainee doctor at Kolkata’s RG Kar Medical College and Hospital. The 10 members of the task force include Vice Admiral Arti Sarin, Director General (Medical Services), Dr D Nageshwar Reddy, Chairman and Managing Director, Asian Institute of Gastroenterology and AIG Hospitals, Hyderabad, Dr M Srinivas, AIIMS-Delhi Director and Dr Pratima Murthy, Director, National Institute of Mental Health and Neurosciences, Bengaluru.
According to the NTF, there are already enough legal provisions to ensure the safety of healthcare professionals. Further, the Task Force pointed out that the Bharatiya Nyaya Sanhita, 2023 (BNS), could handle heinous offences against doctors and medical staff.
“It has been observed that State laws have adequate provisions to address day-to-day minor offences and serious offences can be addressed by BNS. A separate Central law to deal with offences against healthcare professionals is, therefore, not required,” reasoned the National Task Force (NTF).
Also Read: Central Law for violence against doctors NOT required! says SC-appointed Task Force
Powered by WPeMatico
Indianapolis:
According to the company, these transitions will further enhance the company’s ability to drive sustained, long-term growth and ensure that its medicines continue to reach millions of people worldwide.
Ilya Yuffa, executive vice president and president,
In this capacity, Yuffa will lead the
Patrik Jonsson, executive vice president and president,
Kenneth Custer, Ph.D., general manager of
“Thanks to Patrik’s leadership, Lilly’s cardiometabolic health and
Powered by WPeMatico
Thiruvananthapuram: After a 31-year-old woman was put on life support after losing her four fingers and toes due to a severe infection following a botched fat removal surgery at a private cosmetic clinic in Thampuranmukku, an expert committee of doctors appointed by the state health department confirmed that the clinic failed to follow standard medical procedures during the surgery.
Despite the patient having dangerously low blood pressure, she was kept for 12 hours without a ventilator at the facility. Additionally, the patient had a history of heart issues, the surgery was performed without the presence of a cardiologist.
Medical Dialogues had recently reported that the incident took place on February 22 when M.S. Neethu, a resident of Sreevaraham in Muttathara, underwent a fat removal procedure on her lower abdomen at the ‘Cosmetic Hospital’ in Arasummoodu, Kazhakoottam. She was discharged the next day, but according to a complaint filed by her husband, Padmajith, she soon developed severe fatigue and other alarming symptoms.
Despite informing the attending doctor, she was reportedly only advised to consume salted porridge and water. Her condition deteriorated rapidly, and on February 24, she was rushed back to the clinic. Staff at the clinic arranged for her transfer to another private hospital, citing complications including dangerously low blood pressure. There, she reportedly suffered a cardiac arrest following the procedure, which was conducted in February. She has been on ventilator support ever since.
Also read- Kerala: Woman’s fingers, toes amputated after botched surgery at private clinic
Currently, the woman is being treated in the ICU of a private hospital, and her condition is said to be improving. On Monday, doctors had to amputate the fifth toe on her left foot and the fourth toe on her left hand due to complications from the surgery.
Raising concerns about serious lapses in the botched cosmetic surgery, the committee pointed out that the basic protocol of monitoring a patient for 24 hours after administering general anaesthesia was not followed. While the patient had dangerously low blood pressure, she was kept for 12 hours in a facility without a ventilator.
As per a latest media report by Kerala Kaumudi, the committee also pointed out that the surgery was carried out even though the woman had informed them about her heart condition. As the patient had a history of heart problems, a cardiologist should have been present to monitor her during the procedure. However, no cardiologist was available during the procedure, said the committee.
The committee also found that the cosmetic clinic, which performed complex surgeries, did not have ambulance facilities and was operating despite not being registered as a medical establishment.
The District Medical Officer (DMO) has now written to the heads of the critical care and radiology departments at the medical college to get their expert opinions on the matter. Including their opinion, the committee will submit a final report in the case.
Also read- C-section Via Phone? Doctor, Hospital booked after nurse performs procedure on 5 month old IVF twins
Powered by WPeMatico
Mumbai: Johnson & Johnson MedTech has onboarded Qure.ai as a
strategic partner with Johnson & Johnson Private Limited, a Johnson & Johnson company, to enhance early detection of lung cancer in India.
This
collaboration brings together cutting-edge AI and medical technology, helping
identify lung cancer at its most treatable stage.
This
initiative is part of Project BreatheEZ, a broader strategic collaboration
between Qure.ai and Johnson & Johnson MedTech, and designed to establish AI-led
Incidental Pulmonary Nodule (IPN) Detection clinics across
leading hospitals in India. These clinics will act as integrated screening
hubs, optimizing early detection, triaging, and follow-up care for lung cancer
patients. As
part of this collaboration, Qure.ai’s AI technology will be deployed across 10
hub medical centers in India, with an additional 20 supporting spoke sites. The
first such clinic has been launched in Thangam Cancer Centre in
Namakkal, Tamil Nadu.
In
India, one in nine persons is likely to be diagnosed with cancer in their
lifetime. It is an increasing health concern, and the projected cancer burden
is expected to rise from 26.7 million DALYs (Disability-Adjusted Life Years) in
2021 to 29.8 million in 2025. This growing health challenge needs
innovative solutions to improve early detection and ultimately save lives. Traditional diagnostic methods often fail to
detect lung cancer at an early stage, leading to delays in treatment.
“By
harnessing of artificial intelligence in the modalities of X-Ray & CT scans,
Johnson & Johnson MedTech India & Qure.ai are enabling the detection of
potential lung nodules that might otherwise be missed. This happens through
flagging risky nodules in X-Rays and CT Scans that can potentially turn out to
be malignant. It also introduces the concept of structured IPN clinics where
there is a proactive impetus towards incidental screening of early-stage lung
cancer. This partnership embodies Johnson & Johnson MedTech’s commitment to
enhancing early lung cancer detection, ultimately transforming the standard of lung
cancer care,” the release stated.
Anuj Virmani, Managing Director, India, Johnson
& Johnson MedTech, said, “Lung cancer continues to be one of the leading
causes of cancer in both men and women. In India, where access to advanced
healthcare facilities is often limited, especially in tier-2 and tier-3 cities,
patients face significant challenges in receiving timely and effective
diagnosis, which further delays access to treatment. Our collaboration with
Qure.ai is a testament to our
commitment to advancing healthcare through innovative solutions continues to
drive impactful collaborations and integrating our solutions in lung cancer.”
Powered by WPeMatico
Thane: Amid escalating cross-border tensions, the Maharashtra chapter of the Indian Medical Association (IMA) has urged doctors in the state to stay vigilant and be fully prepared to provide emergency services to citizens.
“In moments of national crisis, the strength of our healthcare system lies not in infrastructure alone, but in the readiness and spirit of its doctors,” said Dr Santosh Kadam, president of IMA’s state chapter, in a statement.
Also Read:Doctors’ bodies call on medical fraternity to gear up
According to the PTI report, the advisory, released late Thursday evening, outlines a seven-point preparedness strategy aimed at ensuring swift and coordinated medical response in the event of a large-scale emergency.
The IMA has directed all member clinics, nursing homes, and hospitals to stock essential emergency medicines, dressing materials, and life-saving drugs.
It has also recommended setting up disaster management task forces in each branch, consisting of senior clinicians, surgeons, anaesthetists, emergency physicians, and volunteers.
Medical Dialogues recently reported that in response to rising tensions between India and Pakistan following the April 22 terror attack in Pahalgam and India’s subsequent retaliatory operation, doctors nationwide are preparing to tackle potential medical emergencies. The Indian Medical Association (IMA) has written to Prime Minister Narendra Modi, pledging its complete support during this critical time. The association has offered to mobilize special medical teams, conduct blood donation drives, establish emergency response units, and launch mental health support programs as necessary.
As tensions escalate, healthcare professionals are aligning resources to ensure timely medical assistance in any scenario that may unfold. “IMA has always stood shoulder to shoulder with the Government of India in every situation of crisis, be it public health emergencies, natural disasters, or national calamities. We are mindful of the evolving a geopolitical scenario and the possibility of a national emergency in the form of a proposed war. We wish to assure you that the entire medical fraternity under the banner of IMA stands with the Government and is prepared to serve our country. Our network of qualified, skilled, and experienced medical professionals is available to extend all necessary healthcare support and services during the time of crisis or national emergency,” the association stated in the letter.
Also Read:Haryana cancels Doctors’ Leave amid rising India-Pakistan tensions
Powered by WPeMatico
Denmark: Zealand Pharma A/S, a biotechnology company focused on the discovery and development of peptide-based medicines, has announced that all closing conditions in the collaboration and license agreement with Roche announced on March 12, 2025 have been satisfied, including regulatory conditions, and the agreement has become effective.
“We are incredibly excited to launch this partnership, which represents a step change to realize Zealand Pharma’s vision of becoming a key player in the future management of obesity. Roche ticked all the right boxes for what we were looking for in a partner and we look very much forward to working closely together to unlock the full potential of petrelintide to benefit people who are overweight or obese”, said Adam Steensberg, Chief Executive Officer at Zealand Pharma.
More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market and three candidates are in late-stage development. The company has development partnerships with a number of pharma companies as well as commercial partnerships for its marketed products.
Zealand was founded in 1998 and is headquartered in Copenhagen, Denmark, with a presence in the United States.
Powered by WPeMatico